XML 51 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity Compensation Plan (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Feb. 09, 2022
Mar. 11, 2020
Dec. 30, 2021
Jun. 22, 2021
Sep. 30, 2022
Sep. 30, 2021
Sep. 25, 2021
Sep. 22, 2021
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Outstanding shares of common stock 5.00%              
Stock-based compensation expense         $ 717,000 $ 1,123,000    
Unamortized stock-based compensation         $ 1,690,000      
Unamortized stock-based compensation period         3 years      
Research and Development Expense [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Stock-based compensation expense         $ 283,000 69,000    
General and Administrative Expense [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Stock-based compensation expense         416,000 1,023,000    
Cost of Sales [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Stock-based compensation expense         $ 18,000 $ 31,000    
N 2019 Equity Compensation Plan [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Number of Shares Authorized 4,600,000              
Chief Executive Officer [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number             25,000 1,911,160
Options Held [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Option grant term     10 years          
Option exercise price     $ 1.77          
Option granted     445,000 388,246        
Equity Compensation Plan description   The grant was reduced to 500,000 options, including 375,000 options and 125,000 options respectively under the two categories, due to limitations under the 2019 Plan. The terms of the 125,000 performance-based options were established in the quarter ended December 31, 2020. The terms of the performance-based options were met during the quarter ended March 31, 2021.            
Number of shares available for grant         2,236,129      
Options Held [Member] | Minimum [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Option exercise price       $ 2.90        
Options Held [Member] | Maximum [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Option exercise price       $ 3.93        
Options Held [Member] | Executive Chairman [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Option grant term   10 years            
Option exercise price   $ 1.50            
Option granted   965,850            
Options Held [Member] | Chief Executive Officer [Member]                
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                
Option granted   321,950